It's suggested that Britain’s home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?
New COVID-19 drug approvals couldn’t be timelier as hospitals face massive backlogs of delayed procedures.
With studies showing COVID-19 vaccine efficacy declining faster than expected, boosters aren’t the only option, and in some cases they may not even be the best.
Former British Prime Minister David Cameron's lobbying for a collapsed finance firm allegedly earned him $10 million for two years of part-time work.
If the last 18 months have taught us anything, it’s that a successful COVID-19 policy requires three things: high levels of public trust, a coherent strategy and effective implementation.
Sturgeon has been weakened, no doubt, but in Westminster only one question matters: how best to keep the union intact.
Trade deals, like peace agreements, aren’t worth the paper they’re printed on without good faith vested in their implementation. Just weeks after the Brexit trade agreement entered into force, intentions over the part of the deal that applies to Northern Ireland have been called into ...
It’s not a great sign when a formerly pro-Brexit lobby is suddenly furious about a part of the deal that was billed as a triumph.
The situation on Britain’s borders is clearly serious, but will it wound Johnson fatally? That all depends on how many Britons are inclined to blame the virus for the chaos.
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
